Ashwagandha

Overview

Ashwagandha (Withania somnifera (L.) Dunal) is a shrub used for centuries in Ayurvedic medicine and known there as a "rasayana" — a tonic meant to restore balance and resilience¹. Modern researchers now call it an adaptogen, a plant thought to help the body cope with stress, and most of the human research backs up that traditional reputation. A 2022 meta-analysis pooling 12 trials and over 1,000 people found that ashwagandha supplementation significantly reduced anxiety and stress scores compared with placebo², and a second 2024 meta-analysis of nine trials with 558 patients confirmed a significant effect on both stress and anxiety measures³. Individual randomized trials point to a possible mechanism: in one 60-day placebo-controlled study, a standardized extract (240 mg/day) lowered self-reported anxiety and stress scale scores alongside measurable drops in cortisol, the body's main stress hormone⁴. A second placebo-controlled trial using 500 mg/day of root extract with a small amount of piperine (a black pepper compound added to aid absorption) similarly improved perceived stress and quality-of-life scores while shifting stress hormone levels⁵.

Beyond stress, a 2021 meta-analysis of five trials in 400 people found a small but statistically significant improvement in overall sleep quality and quantity with ashwagandha extract compared with placebo⁶. A separate 8-week randomized trial in people with subclinical hypothyroidism (a mild, often symptom-free underactive thyroid) found that 600 mg/day of root extract improved thyroid-stimulating hormone (TSH) levels compared with placebo¹. One published case report also described a 72-year-old man with Parkinson's disease whose tremor and mobility improved after two months on a combination of ashwagandha and Kapikachhu within an Ayurvedic treatment plan — a single case, not a controlled trial, so it can only be read as a preliminary observation⁷. Early-stage laboratory and animal research has also looked at ashwagandha's compounds (withanolides) for potential effects on tumor cells, including a small phase 1 human safety trial of a purified leaf-extract drug candidate in lung cancer patients, but this work is preliminary and does not establish an anticancer effect in people^8,9.

Dosage

Studies used a range of standardized root extract doses: 240 mg/day of a standardized extract (Shoden) for 60 days in one anxiety/stress trial⁴; 500 mg/day of root extract standardized to 2.5% withanolides, combined with 5 mg piperine, for 60 days in another stress trial (equivalent to about 12.5 mg withanolides/day)⁵; and 600 mg/day of root extract for 8 weeks in the subclinical hypothyroidism trial¹. The sleep meta-analysis pooled five trials using varying extract doses and did not report one single universal amount⁶. No dosage data for pregnancy, children, or long-term (multi-month or multi-year) use was found in the reviewed studies.

Interactions

Documented supplement-drug interaction data flag ashwagandha root extract as interacting with nitric oxide pathways, 3,4-methylenedioxyamphetamine (MDMA), antioxidants, central nervous system stimulants, corticosterone, glutathione, and the thyroid medication propylthiouracil. Because a clinical trial found ashwagandha changed TSH (thyroid-stimulating hormone) levels in people with subclinical hypothyroidism, it should be treated as potentially interacting with thyroid medications specifically, and thyroid function should be monitored¹. No interaction data with common sedatives, antidepressants, or anticoagulant medications was found in the reviewed clinical trials.

Traditional Use

Ashwagandha is documented in two of the seven traditions tracked here, and the reason for the other five is geography rather than a gap in searching: the plant grows across South Asia, the Middle East and the Mediterranean — Pakistan, Israel, Saudi Arabia, India, Greece, Spain — and nowhere in East Asia, so the classical systems of China, Japan and Korea had no access to it and it carries no name in their drug lists. Europe is the odd one out. The plant does grow in Spain and Greece, yet no European book of remedies records it, and when the European Medicines Agency assessed the root it declined to issue a monograph and published a public statement instead. One warning belongs with that: EMA files the root under the name "winter cherry", but the winter cherry of the old European and American compendia is Physalis alkekengi — a different plant in a different genus.

What biohacking says

Evidence Strength

Ashwagandha for stress and anxiety is backed by unusually consistent evidence for a botanical supplement: three meta-analyses pooling multiple randomized trials, plus individual placebo-controlled trials showing hormonal changes that align with the symptom improvements. The sleep evidence is real but modest — a small but statistically significant effect across five trials. The thyroid finding comes from a single pilot trial and needs replication before being treated as settled. Claims about cancer or Parkinson's disease rest on a single case report and preliminary lab/animal or early-phase safety research, and should be read as hypothesis-generating rather than proven effects in people.